Renagel sevelamer: Pilot study; marketed to reduce serum phosphorus in patients with end-stage renal disease who are on hemodialysis.

GELX and partner Genzyme (GENZ, Cambridge, Mass.)

Read the full 73 word article

How to gain access

Continue reading with a
two-week free trial.